Global Regenerative Medicine Market Insights and Forecast to 2028

Publisher Name :
Date: 31-Jan-2022
No. of pages: 125
Inquire Before Buying

Regenerative Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Regenerative Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Cell Therapy

- Tissue Engineering

- Biomaterial

- Other

Segment by Application

- Dermatology

- Cardiovascular

- CNS

- Orthopedic

- Others

By Company

- J & J (DePuy Synthes)

- Medtronic

- Zimmer Biomet

- Stryker

- Allergan(Acelity)

- MiMedx Group

- Organogenesis

- Fujifilm Cellular Dynamics

- Osiris Therapeutics

- Vcanbio

- CCBC

- Cytori

- Celgene

- Vericel Corporation

- Guanhao Biotech

- Mesoblast

- AMAG Pharmaceuticals (CBR)

- ViaCord

- CordLife

- Integra LifeSciences

- Nuvasive

- Cook Biotech

- Japan Tissue Engineering

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Regenerative Medicine Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Regenerative Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Cell Therapy
1.2.3 Tissue Engineering
1.2.4 Biomaterial
1.2.5 Other
1.3 Market by Application
1.3.1 Global Regenerative Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Regenerative Medicine Market Perspective (2017-2028)
2.2 Regenerative Medicine Growth Trends by Region
2.2.1 Regenerative Medicine Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Regenerative Medicine Historic Market Size by Region (2017-2022)
2.2.3 Regenerative Medicine Forecasted Market Size by Region (2023-2028)
2.3 Regenerative Medicine Market Dynamics
2.3.1 Regenerative Medicine Industry Trends
2.3.2 Regenerative Medicine Market Drivers
2.3.3 Regenerative Medicine Market Challenges
2.3.4 Regenerative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Regenerative Medicine Players by Revenue
3.1.1 Global Top Regenerative Medicine Players by Revenue (2017-2022)
3.1.2 Global Regenerative Medicine Revenue Market Share by Players (2017-2022)
3.2 Global Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Regenerative Medicine Revenue
3.4 Global Regenerative Medicine Market Concentration Ratio
3.4.1 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Regenerative Medicine Revenue in 2021
3.5 Regenerative Medicine Key Players Head office and Area Served
3.6 Key Players Regenerative Medicine Product Solution and Service
3.7 Date of Enter into Regenerative Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Regenerative Medicine Breakdown Data by Type
4.1 Global Regenerative Medicine Historic Market Size by Type (2017-2022)
4.2 Global Regenerative Medicine Forecasted Market Size by Type (2023-2028)
5 Regenerative Medicine Breakdown Data by Application
5.1 Global Regenerative Medicine Historic Market Size by Application (2017-2022)
5.2 Global Regenerative Medicine Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Regenerative Medicine Market Size (2017-2028)
6.2 North America Regenerative Medicine Market Size by Type
6.2.1 North America Regenerative Medicine Market Size by Type (2017-2022)
6.2.2 North America Regenerative Medicine Market Size by Type (2023-2028)
6.2.3 North America Regenerative Medicine Market Share by Type (2017-2028)
6.3 North America Regenerative Medicine Market Size by Application
6.3.1 North America Regenerative Medicine Market Size by Application (2017-2022)
6.3.2 North America Regenerative Medicine Market Size by Application (2023-2028)
6.3.3 North America Regenerative Medicine Market Share by Application (2017-2028)
6.4 North America Regenerative Medicine Market Size by Country
6.4.1 North America Regenerative Medicine Market Size by Country (2017-2022)
6.4.2 North America Regenerative Medicine Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Regenerative Medicine Market Size (2017-2028)
7.2 Europe Regenerative Medicine Market Size by Type
7.2.1 Europe Regenerative Medicine Market Size by Type (2017-2022)
7.2.2 Europe Regenerative Medicine Market Size by Type (2023-2028)
7.2.3 Europe Regenerative Medicine Market Share by Type (2017-2028)
7.3 Europe Regenerative Medicine Market Size by Application
7.3.1 Europe Regenerative Medicine Market Size by Application (2017-2022)
7.3.2 Europe Regenerative Medicine Market Size by Application (2023-2028)
7.3.3 Europe Regenerative Medicine Market Share by Application (2017-2028)
7.4 Europe Regenerative Medicine Market Size by Country
7.4.1 Europe Regenerative Medicine Market Size by Country (2017-2022)
7.4.2 Europe Regenerative Medicine Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Market Size (2017-2028)
8.2 Asia-Pacific Regenerative Medicine Market Size by Type
8.2.1 Asia-Pacific Regenerative Medicine Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Regenerative Medicine Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Regenerative Medicine Market Share by Type (2017-2028)
8.3 Asia-Pacific Regenerative Medicine Market Size by Application
8.3.1 Asia-Pacific Regenerative Medicine Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Regenerative Medicine Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Regenerative Medicine Market Share by Application (2017-2028)
8.4 Asia-Pacific Regenerative Medicine Market Size by Region
8.4.1 Asia-Pacific Regenerative Medicine Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Regenerative Medicine Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Regenerative Medicine Market Size (2017-2028)
9.2 Latin America Regenerative Medicine Market Size by Type
9.2.1 Latin America Regenerative Medicine Market Size by Type (2017-2022)
9.2.2 Latin America Regenerative Medicine Market Size by Type (2023-2028)
9.2.3 Latin America Regenerative Medicine Market Share by Type (2017-2028)
9.3 Latin America Regenerative Medicine Market Size by Application
9.3.1 Latin America Regenerative Medicine Market Size by Application (2017-2022)
9.3.2 Latin America Regenerative Medicine Market Size by Application (2023-2028)
9.3.3 Latin America Regenerative Medicine Market Share by Application (2017-2028)
9.4 Latin America Regenerative Medicine Market Size by Country
9.4.1 Latin America Regenerative Medicine Market Size by Country (2017-2022)
9.4.2 Latin America Regenerative Medicine Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Market Size (2017-2028)
10.2 Middle East & Africa Regenerative Medicine Market Size by Type
10.2.1 Middle East & Africa Regenerative Medicine Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Regenerative Medicine Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Regenerative Medicine Market Share by Type (2017-2028)
10.3 Middle East & Africa Regenerative Medicine Market Size by Application
10.3.1 Middle East & Africa Regenerative Medicine Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Regenerative Medicine Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Regenerative Medicine Market Share by Application (2017-2028)
10.4 Middle East & Africa Regenerative Medicine Market Size by Country
10.4.1 Middle East & Africa Regenerative Medicine Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Regenerative Medicine Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 J & J (DePuy Synthes)
11.1.1 J & J (DePuy Synthes) Company Details
11.1.2 J & J (DePuy Synthes) Business Overview
11.1.3 J & J (DePuy Synthes) Regenerative Medicine Introduction
11.1.4 J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022)
11.1.5 J & J (DePuy Synthes) Recent Developments
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Medtronic Business Overview
11.2.3 Medtronic Regenerative Medicine Introduction
11.2.4 Medtronic Revenue in Regenerative Medicine Business (2017-2022)
11.2.5 Medtronic Recent Developments
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Details
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Regenerative Medicine Introduction
11.3.4 Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022)
11.3.5 Zimmer Biomet Recent Developments
11.4 Stryker
11.4.1 Stryker Company Details
11.4.2 Stryker Business Overview
11.4.3 Stryker Regenerative Medicine Introduction
11.4.4 Stryker Revenue in Regenerative Medicine Business (2017-2022)
11.4.5 Stryker Recent Developments
11.5 Allergan(Acelity)
11.5.1 Allergan(Acelity) Company Details
11.5.2 Allergan(Acelity) Business Overview
11.5.3 Allergan(Acelity) Regenerative Medicine Introduction
11.5.4 Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022)
11.5.5 Allergan(Acelity) Recent Developments
11.6 MiMedx Group
11.6.1 MiMedx Group Company Details
11.6.2 MiMedx Group Business Overview
11.6.3 MiMedx Group Regenerative Medicine Introduction
11.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2017-2022)
11.6.5 MiMedx Group Recent Developments
11.7 Organogenesis
11.7.1 Organogenesis Company Details
11.7.2 Organogenesis Business Overview
11.7.3 Organogenesis Regenerative Medicine Introduction
11.7.4 Organogenesis Revenue in Regenerative Medicine Business (2017-2022)
11.7.5 Organogenesis Recent Developments
11.8 Fujifilm Cellular Dynamics
11.8.1 Fujifilm Cellular Dynamics Company Details
11.8.2 Fujifilm Cellular Dynamics Business Overview
11.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Introduction
11.8.4 Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022)
11.8.5 Fujifilm Cellular Dynamics Recent Developments
11.9 Osiris Therapeutics
11.9.1 Osiris Therapeutics Company Details
11.9.2 Osiris Therapeutics Business Overview
11.9.3 Osiris Therapeutics Regenerative Medicine Introduction
11.9.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022)
11.9.5 Osiris Therapeutics Recent Developments
11.10 Vcanbio
11.10.1 Vcanbio Company Details
11.10.2 Vcanbio Business Overview
11.10.3 Vcanbio Regenerative Medicine Introduction
11.10.4 Vcanbio Revenue in Regenerative Medicine Business (2017-2022)
11.10.5 Vcanbio Recent Developments
11.11 CCBC
11.11.1 CCBC Company Details
11.11.2 CCBC Business Overview
11.11.3 CCBC Regenerative Medicine Introduction
11.11.4 CCBC Revenue in Regenerative Medicine Business (2017-2022)
11.11.5 CCBC Recent Developments
11.12 Cytori
11.12.1 Cytori Company Details
11.12.2 Cytori Business Overview
11.12.3 Cytori Regenerative Medicine Introduction
11.12.4 Cytori Revenue in Regenerative Medicine Business (2017-2022)
11.12.5 Cytori Recent Developments
11.13 Celgene
11.13.1 Celgene Company Details
11.13.2 Celgene Business Overview
11.13.3 Celgene Regenerative Medicine Introduction
11.13.4 Celgene Revenue in Regenerative Medicine Business (2017-2022)
11.13.5 Celgene Recent Developments
11.14 Vericel Corporation
11.14.1 Vericel Corporation Company Details
11.14.2 Vericel Corporation Business Overview
11.14.3 Vericel Corporation Regenerative Medicine Introduction
11.14.4 Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022)
11.14.5 Vericel Corporation Recent Developments
11.15 Guanhao Biotech
11.15.1 Guanhao Biotech Company Details
11.15.2 Guanhao Biotech Business Overview
11.15.3 Guanhao Biotech Regenerative Medicine Introduction
11.15.4 Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022)
11.15.5 Guanhao Biotech Recent Developments
11.16 Mesoblast
11.16.1 Mesoblast Company Details
11.16.2 Mesoblast Business Overview
11.16.3 Mesoblast Regenerative Medicine Introduction
11.16.4 Mesoblast Revenue in Regenerative Medicine Business (2017-2022)
11.16.5 Mesoblast Recent Developments
11.17 AMAG Pharmaceuticals (CBR)
11.17.1 AMAG Pharmaceuticals (CBR) Company Details
11.17.2 AMAG Pharmaceuticals (CBR) Business Overview
11.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Introduction
11.17.4 AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022)
11.17.5 AMAG Pharmaceuticals (CBR) Recent Developments
11.18 ViaCord
11.18.1 ViaCord Company Details
11.18.2 ViaCord Business Overview
11.18.3 ViaCord Regenerative Medicine Introduction
11.18.4 ViaCord Revenue in Regenerative Medicine Business (2017-2022)
11.18.5 ViaCord Recent Developments
11.19 CordLife
11.19.1 CordLife Company Details
11.19.2 CordLife Business Overview
11.19.3 CordLife Regenerative Medicine Introduction
11.19.4 CordLife Revenue in Regenerative Medicine Business (2017-2022)
11.19.5 CordLife Recent Developments
11.20 Integra LifeSciences
11.20.1 Integra LifeSciences Company Details
11.20.2 Integra LifeSciences Business Overview
11.20.3 Integra LifeSciences Regenerative Medicine Introduction
11.20.4 Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022)
11.20.5 Integra LifeSciences Recent Developments
11.21 Nuvasive
11.21.1 Nuvasive Company Details
11.21.2 Nuvasive Business Overview
11.21.3 Nuvasive Regenerative Medicine Introduction
11.21.4 Nuvasive Revenue in Regenerative Medicine Business (2017-2022)
11.21.5 Nuvasive Recent Developments
11.22 Cook Biotech
11.22.1 Cook Biotech Company Details
11.22.2 Cook Biotech Business Overview
11.22.3 Cook Biotech Regenerative Medicine Introduction
11.22.4 Cook Biotech Revenue in Regenerative Medicine Business (2017-2022)
11.22.5 Cook Biotech Recent Developments
11.23 Japan Tissue Engineering
11.23.1 Japan Tissue Engineering Company Details
11.23.2 Japan Tissue Engineering Business Overview
11.23.3 Japan Tissue Engineering Regenerative Medicine Introduction
11.23.4 Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022)
11.23.5 Japan Tissue Engineering Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Cell Therapy
Table 3. Key Players of Tissue Engineering
Table 4. Key Players of Biomaterial
Table 5. Key Players of Other
Table 6. Global Regenerative Medicine Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Regenerative Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Regenerative Medicine Market Share by Region (2017-2022)
Table 10. Global Regenerative Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Regenerative Medicine Market Share by Region (2023-2028)
Table 12. Regenerative Medicine Market Trends
Table 13. Regenerative Medicine Market Drivers
Table 14. Regenerative Medicine Market Challenges
Table 15. Regenerative Medicine Market Restraints
Table 16. Global Regenerative Medicine Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Regenerative Medicine Revenue Share by Players (2017-2022)
Table 18. Global Top Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021)
Table 19. Ranking of Global Top Regenerative Medicine Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Regenerative Medicine Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Regenerative Medicine Product Solution and Service
Table 23. Date of Enter into Regenerative Medicine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Regenerative Medicine Revenue Market Share by Type (2017-2022)
Table 27. Global Regenerative Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Regenerative Medicine Revenue Market Share by Type (2023-2028)
Table 29. Global Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Regenerative Medicine Revenue Share by Application (2017-2022)
Table 31. Global Regenerative Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Regenerative Medicine Revenue Share by Application (2023-2028)
Table 33. North America Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Regenerative Medicine Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Regenerative Medicine Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Regenerative Medicine Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Regenerative Medicine Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Regenerative Medicine Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Regenerative Medicine Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Regenerative Medicine Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Regenerative Medicine Market Size by Country (2023-2028) & (US$ Million)
Table 63. J & J (DePuy Synthes) Company Details
Table 64. J & J (DePuy Synthes) Business Overview
Table 65. J & J (DePuy Synthes) Regenerative Medicine Product
Table 66. J & J (DePuy Synthes) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 67. J & J (DePuy Synthes) Recent Developments
Table 68. Medtronic Company Details
Table 69. Medtronic Business Overview
Table 70. Medtronic Regenerative Medicine Product
Table 71. Medtronic Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 72. Medtronic Recent Developments
Table 73. Zimmer Biomet Company Details
Table 74. Zimmer Biomet Business Overview
Table 75. Zimmer Biomet Regenerative Medicine Product
Table 76. Zimmer Biomet Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 77. Zimmer Biomet Recent Developments
Table 78. Stryker Company Details
Table 79. Stryker Business Overview
Table 80. Stryker Regenerative Medicine Product
Table 81. Stryker Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 82. Stryker Recent Developments
Table 83. Allergan(Acelity) Company Details
Table 84. Allergan(Acelity) Business Overview
Table 85. Allergan(Acelity) Regenerative Medicine Product
Table 86. Allergan(Acelity) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 87. Allergan(Acelity) Recent Developments
Table 88. MiMedx Group Company Details
Table 89. MiMedx Group Business Overview
Table 90. MiMedx Group Regenerative Medicine Product
Table 91. MiMedx Group Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 92. MiMedx Group Recent Developments
Table 93. Organogenesis Company Details
Table 94. Organogenesis Business Overview
Table 95. Organogenesis Regenerative Medicine Product
Table 96. Organogenesis Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 97. Organogenesis Recent Developments
Table 98. Fujifilm Cellular Dynamics Company Details
Table 99. Fujifilm Cellular Dynamics Business Overview
Table 100. Fujifilm Cellular Dynamics Regenerative Medicine Product
Table 101. Fujifilm Cellular Dynamics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 102. Fujifilm Cellular Dynamics Recent Developments
Table 103. Osiris Therapeutics Company Details
Table 104. Osiris Therapeutics Business Overview
Table 105. Osiris Therapeutics Regenerative Medicine Product
Table 106. Osiris Therapeutics Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 107. Osiris Therapeutics Recent Developments
Table 108. Vcanbio Company Details
Table 109. Vcanbio Business Overview
Table 110. Vcanbio Regenerative Medicine Product
Table 111. Vcanbio Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 112. Vcanbio Recent Developments
Table 113. CCBC Company Details
Table 114. CCBC Business Overview
Table 115. CCBC Regenerative Medicine Product
Table 116. CCBC Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 117. CCBC Recent Developments
Table 118. Cytori Company Details
Table 119. Cytori Business Overview
Table 120. Cytori Regenerative Medicine Product
Table 121. Cytori Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 122. Cytori Recent Developments
Table 123. Celgene Company Details
Table 124. Celgene Business Overview
Table 125. Celgene Regenerative Medicine Product
Table 126. Celgene Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 127. Celgene Recent Developments
Table 128. Vericel Corporation Company Details
Table 129. Vericel Corporation Business Overview
Table 130. Vericel Corporation Regenerative Medicine Product
Table 131. Vericel Corporation Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 132. Vericel Corporation Recent Developments
Table 133. Guanhao Biotech Company Details
Table 134. Guanhao Biotech Business Overview
Table 135. Guanhao Biotech Regenerative Medicine Product
Table 136. Guanhao Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 137. Guanhao Biotech Recent Developments
Table 138. Mesoblast Company Details
Table 139. Mesoblast Business Overview
Table 140. Mesoblast Regenerative Medicine Product
Table 141. Mesoblast Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 142. Mesoblast Recent Developments
Table 143. AMAG Pharmaceuticals (CBR) Company Details
Table 144. AMAG Pharmaceuticals (CBR) Business Overview
Table 145. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product
Table 146. AMAG Pharmaceuticals (CBR) Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 147. AMAG Pharmaceuticals (CBR) Recent Developments
Table 148. ViaCord Company Details
Table 149. ViaCord Business Overview
Table 150. ViaCord Regenerative Medicine Product
Table 151. ViaCord Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 152. ViaCord Recent Developments
Table 153. CordLife Company Details
Table 154. CordLife Business Overview
Table 155. CordLife Regenerative Medicine Product
Table 156. CordLife Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 157. CordLife Recent Developments
Table 158. Integra LifeSciences Company Details
Table 159. Integra LifeSciences Business Overview
Table 160. Integra LifeSciences Regenerative Medicine Product
Table 161. Integra LifeSciences Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 162. Integra LifeSciences Recent Developments
Table 163. Nuvasive Company Details
Table 164. Nuvasive Business Overview
Table 165. Nuvasive Regenerative Medicine Product
Table 166. Nuvasive Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 167. Nuvasive Recent Developments
Table 168. Cook Biotech Company Details
Table 169. Cook Biotech Business Overview
Table 170. Cook Biotech Regenerative Medicine Product
Table 171. Cook Biotech Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 172. Cook Biotech Recent Developments
Table 173. Japan Tissue Engineering Company Details
Table 174. Japan Tissue Engineering Business Overview
Table 175. Japan Tissue Engineering Regenerative Medicine Product
Table 176. Japan Tissue Engineering Revenue in Regenerative Medicine Business (2017-2022) & (US$ Million)
Table 177. Japan Tissue Engineering Recent Developments
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Regenerative Medicine Market Share by Type: 2021 VS 2028
Figure 2. Cell Therapy Features
Figure 3. Tissue Engineering Features
Figure 4. Biomaterial Features
Figure 5. Other Features
Figure 6. Global Regenerative Medicine Market Share by Application: 2021 VS 2028
Figure 7. Dermatology Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. CNS Case Studies
Figure 10. Orthopedic Case Studies
Figure 11. Others Case Studies
Figure 12. Regenerative Medicine Report Years Considered
Figure 13. Global Regenerative Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Regenerative Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Regenerative Medicine Market Share by Region: 2021 VS 2028
Figure 16. Global Regenerative Medicine Market Share by Players in 2021
Figure 17. Global Top Regenerative Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Regenerative Medicine as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Regenerative Medicine Revenue in 2021
Figure 19. North America Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Regenerative Medicine Market Size Market Share by Type (2017-2028)
Figure 21. North America Regenerative Medicine Market Size Market Share by Application (2017-2028)
Figure 22. North America Regenerative Medicine Market Size Share by Country (2017-2028)
Figure 23. United States Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Regenerative Medicine Market Size Market Share by Type (2017-2028)
Figure 27. Europe Regenerative Medicine Market Size Market Share by Application (2017-2028)
Figure 28. Europe Regenerative Medicine Market Size Share by Country (2017-2028)
Figure 29. Germany Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Regenerative Medicine Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Regenerative Medicine Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Regenerative Medicine Market Size Share by Region (2017-2028)
Figure 39. China Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Latin America Regenerative Medicine Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Regenerative Medicine Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Regenerative Medicine Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Regenerative Medicine Market Size Share by Country (2017-2028)
Figure 49. Mexico Regenerative Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Regenerative Medicine Market Size
  • Global Tissue Engineered Skin Substitutes Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
  • Global Tissue Engineering Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
  • Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150
    According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
  • Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
  • Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
  • Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96
    The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
  • Global Tissue Engineering and Regeneration Market Research Report 2023
    Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......
  • Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Regenerative Medicine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950
    Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs